Lv1
50 积分 2023-07-08 加入
Real-world data of anlotinib for gynecologic tumors with liver metastases in China
2天前
求助中
Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials
2天前
已完结
[Research advances in the different molecular subtypes of uterine mesenchymal tumors]
19天前
已完结
Real-world data of anlotinib for gynecologic tumors with liver metastases in China
20天前
已关闭
ZC3H7B-BCOR high-grade endometrial stromal sarcomas: a report of 17 cases of a newly defined entity
29天前
已完结
ZC3H7B-BCOR-Rearranged Endometrial Stromal Sarcomas: A Distinct Subset Merits its Own Classification?
29天前
已完结
ZC3H7B-BCOR Fusion High-grade Endometrial Stromal Sarcoma With Morphologic Features of Low-grade Endometrial Stromal Sarcoma. A Case Report and Review of Literature
29天前
已完结
Adding immunotherapy to first-line treatment of advanced and metastatic endometrial cancer
1个月前
已完结
Pelvic radiotherapy combined with immunotherapy and chemotherapy for stage IVB cervical cancer: a retrospective study
1个月前
已完结
Molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer (PORTEC-4a): results of a randomised, open-label, phase 3, multicentre, non-inferiority trial
2个月前
已完结
皖公网安备34019202002308
